Advertisement

Tubulointerstitial Nephritis

Chapter

Abstract

In 1898, Councilman described lymphoid and plasma cell infiltrates in the renal interstitium which he termed ‘acute interstitial nephritis’. This arose in the setting of infectious diseases such as diphtheria and scarlet fever. The report specifically states that there was no evidence of local infection. Neutrophils were identified only in the presence of significant tissue necrosis. This contrasted acute interstitial nephritis (AIN) with acute pyelonephritis, caused by ascending bacterial infection. Councilman’s report of AIN includes clinical features recognisable in contemporary practice, such as a relative lack of peripheral oedema in comparison to glomerulonephritis.

Keywords

Acute Kidney Injury Renal Biopsy Interstitial Nephritis Renal Tubular Acidosis Aristolochic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Goicoechea M, Rivera F, Lopez-Gomez JM. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2013;28:112–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Leonard CE, Freeman CP, Newcomb CW, Reese PP, Herlim M, Bilker WB, et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf. 2012;21:1155–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Farrington K, Levison DA, Greenwood RN, Cattell WR, Baker LR. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med. 1989;70(263):221–33. Epub 1989/03/01.PubMedGoogle Scholar
  4. 4.
    Ball S, Cook T, Hulme B, Palmer A, Taube D. The diagnosis and racial origin of 394 patients undergoing renal biopsy: an association between Indian race and interstitial nephritis. Nephrol Dial Transplant. 1997;12(1):71–7. Epub 1997/01/01.PubMedCrossRefGoogle Scholar
  5. 5.
    Ball S, Lloyd J, Cairns T, Cook T, Palmer A, Cattell V, et al. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians? QJM. 2001;94(4):187–93. Epub 2001/04/11.PubMedCrossRefGoogle Scholar
  6. 6.
    Harmark L, van der Wiel HE, de Groot MC, van Grootheest AC. Proton pump inhibitor-induced acute interstitial nephritis. Br J Clin Pharmacol. 2007;64(6):819–23. Epub 2007/07/20.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol. 1999;47(2):203–10. Epub 1999/04/06.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, et al. Renal involvement in primary Sjogren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4(9):1423–31. Epub 2009/08/15.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Gobel U, Kettritz R, Schneider W, Luft F. The protean face of renal sarcoidosis. J Am Soc Nephrol. 2001;12(3):616–23.PubMedGoogle Scholar
  10. 10.
    Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore). 2000;79(4):241–9. Epub 2000/08/15.CrossRefGoogle Scholar
  11. 11.
    Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343–52. Epub 2011/07/02.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 2011;63(6):865–74. Epub 2011/02/11.CrossRefGoogle Scholar
  13. 13.
    Banerjee A, McKane W, Thiru S, Farrington K. Wegener’s granulomatosis presenting as acute suppurative interstitial nephritis. J Clin Pathol. 2001;54(10):787–9.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Fhogartaigh CN, Newsholme W, Kinirons M, Tong W. An emerging infectious cause of renal impairment in the UK. BMJ case reports. 2011. Epub 2011/01/01.Google Scholar
  15. 15.
    Cataudella JA, Young ID, Iliescu EA. Epstein-Barr virus-associated acute interstitial nephritis: infection or immunologic phenomenon? Nephron. 2002;92(2):437–9. Epub 2002/09/10.PubMedCrossRefGoogle Scholar
  16. 16.
    Becker JL, Miller F, Nuovo GJ, Josepovitz C, Schubach WH, Nord EP. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest. 1999;104(12):1673–81.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Mansur A, Little MA, Oh WC, Jacques S, Nightingale P, Howie AJ, et al. Immune profile and Epstein-Barr virus infection in acute interstitial nephritis: an immunohistochemical study in 78 patients. Nephron Clin Pract. 2011;119(4):c293–300. Epub 2011/09/29.PubMedCrossRefGoogle Scholar
  18. 18.
    Gonzalez E, Gutierrez E, Galeano C, Chevia C, de Sequera P, Bernis C, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008;73(8):940–6. Epub 2008/01/11.PubMedCrossRefGoogle Scholar
  19. 19.
    Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon P, et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004;19(11):2778–83. Epub 2004/09/02.PubMedCrossRefGoogle Scholar
  20. 20.
    Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int. 2010;77(11):956–61. Epub 2010/03/26.PubMedCrossRefGoogle Scholar
  21. 21.
    Jelakovic B, Karanovic S, Vukovic-Lela I, Miller F, Edwards KL, Nikolic J, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012;81(6):559–67. Epub 2011/11/11.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–8. Epub 2012/01/24.PubMedCrossRefGoogle Scholar
  23. 23.
    Bassilios N, Martel P, Godard V, Froissart M, Grunfeld JP, Stengel B, et al. Monitoring of glomerular filtration rate in lithium-treated outpatients–an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23(2):562–5.Google Scholar
  24. 24.
    Bendz H, Schon S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77(3):219–24.PubMedCrossRefGoogle Scholar
  25. 25.
    Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. [Review]. Nat Rev Nephrol. 2009;5(5):270–6.Google Scholar
  26. 26.
    Bouquegneau A, Dubois BE, Krzesinski JM, Delanaye P. Anorexia nervosa and the kidney. Am J Kidney Dis. 2012;60(2):299–307. Epub 2012/05/23.PubMedCrossRefGoogle Scholar
  27. 27.
    De Broe ME, Elseviers MM. Analgesic nephropathy. [Review]. N Engl J Med. 1998;338(7):446–52.Google Scholar
  28. 28.
    Ball ST, Lapsley M, Norden AG, Cairns TD, Palmer AB, Taube DH. Urinary retinol binding protein in Indo-Asian patients with idiopathic interstitial nephritis. QJM. 2003;96(5):363–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of NephrologyQueen Elizabeth Hospital BirminghamBirminghamUK

Personalised recommendations